Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

Excited to share my updated professional journey, reflecting over 20 years of impactful contributions to public health, research, and education. Passionate about driving innovation and evidence-based solutions, here is my biography.

Excited to share my professional journey in NGS cancer diagnostics, biotech, and healthcare innovation! With over 20 years of experience spanning product management, AI-driven automation, clinical trials, and regulatory compliance, I have led multi-billion-dollar product launches and driven transformative advancements in precision medicine and oncology. My expertise in agile methodologies, strategic planning, and cross-functional leadership has enabled me to bridge science and business for impactful solutions. Here is my biography.

With over 52 years of experience, Gerry Hogue is a trailblazing executive, entrepreneur, and independent director who has transformed the healthcare and high-tech industries through innovative leadership and strategic expertise. As the co-founder and CEO of VieCure Inc., Gerry led the development of a patented AI-driven oncology platform, securing over $50 million in funding and revolutionizing cancer care delivery. His distinguished board service, including roles at Point Biopharma and Precision Cancer Technologies, reflects his commitment to driving growth, improving governance, and fostering innovation. Known for his strategic foresight, mentorship, and international expertise, Gerry continues to make an indelible impact on organizations striving for transformative growth.

I'm excited to share my journey and experiences in oncology, cancer research, and precision medicine. Over the past 32 years, I’ve had the privilege of founding and leading institutions dedicated to advancing cancer care and improving patient outcomes through innovative research and clinical trials. From my work at the Kentucky Cancer Group to my time as Director of Precision Medicine at Norton Cancer Institute, I’ve focused on integrating cutting-edge therapies and a compassionate approach to oncology. Check out my executive biography to learn more about my work and how I'm committed to pushing the boundaries of cancer care through leadership and collaboration.

I’m excited to share a glimpse into my professional journey and achievements. With a Ph.D. in Immunology from the Hebrew University of Jerusalem and extensive experience at the National Institute of Allergy and Infectious Diseases (NIAID), I’ve had the privilege of leading transformative research in cancer immunotherapy and PET imaging of cancer biomarkers. My work has focused on advancing personalized medicine and targeted therapies, and I’m passionate about driving innovation in these fields. I invite you to explore my career highlights and contributions, which reflect my commitment to impactful research and visionary leadership. Thank you for your support and interest!